Stock Groups

India’s Omicron wave may intensify in coming weeks -experts -Breaking

© Reuters. The treatment for the coronavirus infection (COVID-19) continues in Ahmedabad. A patient with a breathing problem is being wheeled to a COVID-19 Hospital. REUTERS/Amit Dave


(Corrects Dr. Subhash Salunke’s designation, paragraph 7)

By Neha Arora

NEW DELHI (Reuters). India’s COVID-19 infected may be on the rise, according to top experts. They noted that Omicron variant is already present in India, and that Omicron hospitals have been treating more people despite a drop in COVID-19 incidences in cities.

India has reported 306,064 cases of new infection in 24 hours. This is a decrease of 8% from the daily average for the past four days. There were 439 deaths, which was the lowest figure in five days.

The weekly positivity rate has risen to 17.03% over the week ending Jan. 24, compared to 0.63% on Dec. 27, a highly-transmissible Omicron variation.

According to an Indian SARS-CoV-2 Genomics Consortium report, Omicron has now become dominant in several metros in India. This was stated in a Sunday report.

The advisory group stated that most Omicron variant cases have been mild. However, hospitalisations were on the rise and intensive care was becoming more common.

After hitting peak levels, major cities like Delhi and Mumbai, the financial hub of Maharashtra have seen huge falls in case numbers in recent weeks.

As the variant spreads to semi-urban, rural areas, Dr. Subhash Salunke said that this could be changing. Salunke previously advised Maharashtra’s government that multiple peak levels are possible in the coming eight to ten weeks.

Salunke said that “the number of cases in cities such as Mumbai and Pune is the tip of an iceberg” adding that there was also a deadly Delta variant of the virus.

India has the second highest number of global infections at 39.54 Million, just behind the United States. It has witnessed 489 848 deaths from the virus.

Disclaimer: Fusion MediaThis website does not provide accurate and current data. CFDs include stocks, indexes and futures. Prices are provided not by the exchanges. Market makers provide them. Therefore, prices can be inaccurate and differ from actual market prices. These prices should not be used for trading. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

Mike Robinson
Mike covers the financial, utilities and biotechnology sectors for Street Register. He has been writing about investment and personal finance topics for almost 12 years. Mike has an MBA in Finance from Wake Forest University.